Abstract
The lipid storage disorders have long been considered primary candidates for enzyme replacement therapy. This goal has been achieved with a remarkable degree of success in Gaucher's disease. Among the accomplishments that were important to obtain clinical benefit were the development of a large-scale procedure to purify human placental glucocerebrosidase and a method to target this enzyme to lipid-storing macrophages through glycoform modification. In addition, the effectiveness of recombinantly produced macrophage-targeted glucorerebrosidase has recently been demonstrated. Because macrophages originate from stem cells in the bone marrow, ex vivo transduction of these cells with retroviral vectors containing the cDNA for human glucocerebrosidase is being explored for the genetic therapy of Gaucher's disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brady, R.O., Kanfer, J.N., and Shapiro, D. (1965) Metabolism of Glucocerebrosides. II. Evidence of an Enzymatic Deficiency in Gaucher's Disease,Biochem. Biophys. Res. Comm. 18, 221–225.
Kattlove, H.E., Williams, J.C., Gaynor, E., Spivack, M., Bradley, R.M., and Brady, R.O. (1969) Gaucher Cells in Chronic Myelocytic Leukemia: An Acquired Abnormality,Blood 33, 379–390.
Brady, R.O. (1966) The Sphingolipidoses,N. Engl. J. Med. 275, 312–318.
Pentchev, P.G., Brady, R.O., Hibbert, S.R., Gal, A.E., and Shapiro, D. (1973) Isolation and Characterization of Glucocerebrosidase from Human Placental Tissue,J. Biol. Chem. 248, 5256–5261.
Brady, R.O., Pentchev, P.G., Gal, A.E., Hibbert, S.R., and Dekaban, A.S. (1974) Replacement Therapy for Inherited Enzyme Deficiency: Use of Purified Glucocerebrosidase in Gaucher's Disease,N. Engl. J. Med. 291, 989–993.
Pentchev, P.G., Brady, R.O., Gal, A.E., and Hibbert, S.R. (1975) Replacement Therapy for Inherited Enzyme Deficiency: Sustained Clearance of Accumulated Glucocerebroside in Gaucher's Disease Following Infusion of Purified Glucocerebrosidase,J. Mol. Med. 1, 73–78.
Furbish, F.S., Blair, H.E., Shiloach, J., Pentchev, P.G., and Brady, R.O. (1977) Enzyme Replacement Therapy in Gaucher's Disease: Large-Scale Purification of Glucocerebrosidase Suitable for Human Administration,Proc. Natl. Acad. Sci. USA 74, 3560–3563.
Goldstone, A., and Keonig, H. (1970) Lysosomal Hydrolases as Glycoproteins,Life Sciences 9, 1341–1350.
Weinreb, N.J., Brady, R.O., and Tappel, A.L. (1968) The Lysosomal Localization of Sphingolipid Hydrolases,Biochim. Biophys. Acta 159, 141–146.
Stahl, P.D., Rodman, J.S., Miller, M.J., and Schlesinger, P.H. (1978). Evidence for Receptor-Mediated Binding of Glycoproteins, Glycoconjugates, and Lysosomal Glycosidases by Alveolar Macrophages,Proc. Natl. Acad. Sci. USA 75, 1399–1403.
Doebber, T.W., Wu, M.S., Bugianesi, R.L., Ponpipom, M.M., Furbish, F.S., Barranger, J.A., Brady, R.O., and Shen, T.Y. (1982) Enhanced Macrophage Uptake of Synthetically Glycosylated Human Placental β-Glucocerebrosidase,J. Biol. Chem. 257, 2193–2199.
Brady, R.O., and Furbish, F.S. (1982) Enzyme Replacement Therapy: Specific Targeting of Exogenous Enzymes to Storage Cells, inMembranes and Transport (Martonosi, A.N. ed.) Vol. 2, pp. 587–592, Plenum Press, New York.
Brady, R.O. and Barton, N.W. (1994) Enzyme Replacement Therapy for Gaucher Disease: Critical Investigations Beyond Demonstration of Clinical Efficacy,Biochem. Med. Metab. Biol. 52, 1–9.
Barton, N.W., Furbish, F.S., Murray, G.J., Garfield, M., and Brady, R.O. (1990) Therapeutic Response to Intravenous Infusions of Glucocerebrosidase in a Patient with Gaucher's Disease,Proc. Natl. Acad. Sci. USA 87, 1913–1916.
Barton, N.W., Brady, R.O., Dambrosia, J.M., DiBisceglie, A.M., Doppelt, S.H., Hill, S.C., Mankin, H.J., Murray, G.J., Parker, R.I., Argoff, C.E., Grewal, R.P., and Yu, K.-T. (1991) Replacement Therapy for Inherited Enzyme Deficiency—Macrophagetargeted Glucocerebrosidase for Gaucher's Disease,N. Engl. J. Med. 324, 1464–1470.
Grabowski, G.A., Barton, N.W., Pastores, G., Dambrosia, J.M., Banerjee, T.K., McKee, M.A., Parker, C., Schiffmann, R., Hill, S.C., and Brady, R.O. (1995) Enzyme Therapy in Gaucher Disease Type 1: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant Sources,Ann. Int. Med. 122, 33–39.
Fink, J.K., Correll, P.H., Perry, L.K., Brady, R.O., and Karlsson, S. (1990) Correction of Glucocerebrosidase Deficiency Following Retroviral-Mediated Gene Transfer into Hematopoietic Progenitor Cells from Patients with Gaucher Disease,Proc. Nat. Acad. Sci. USA 87, 2334–2338.
Correll, P.H., Colilla, S., Dave, H.P.G., and Karlsson, S. (1992) High Levels of Human Glucocerebrosidase Activity in Macro-phages of Long-Term Reconstituted Mice After Retroviral Infection of Hematopoietic Stem Cells,Blood 80, 331–336.
Xu, L.C., Karlsson, S., Burne, E.R., Kluepfel-Stahl S., Kessler, S.W., Agricola, B.A., Sellers, S., Kirby, M., Dunbar, C., Brady, R.O., Nienhuis, A.W., and Donahue, R.E. (1995) Long-Term in Vivo Expression of the Human Glucocerebrosidase Gene in Non-Human Primates After CD34+ Hematopoietic Cell Transduction with Cell-Free Retroviral Vector Preparations,Proc. Natl. Acad. Sci. USA 92, 4372–4376.
Author information
Authors and Affiliations
About this article
Cite this article
Brady, R.O., Barton, N.W. Enzyme replacement and gene therapy for Gaucher's disease. Lipids 31, S137–S139 (1996). https://doi.org/10.1007/BF02637065
Issue Date:
DOI: https://doi.org/10.1007/BF02637065